Pharmacyte Biotech Inc. buy Sievi
Start price
25.08.21
/
50%
€3.05
Target price
25.08.22
-
Performance (%)
-8.85%
End price
14.09.21
€2.78
Summary
This prediction ended on 14.09.21 with a price of €2.78. With a performance of -8.85%, the BUY prediction for Pharmacyte Biotech Inc. by Sievi closed slightly in the red. Sievi has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Pharmacyte Biotech Inc. | - | - | - | - |
| iShares Core DAX® | -0.874% | 5.325% | 6.865% | 65.211% |
| iShares Nasdaq 100 | -0.381% | 1.979% | 25.696% | 90.325% |
| iShares Nikkei 225® | -1.676% | 1.952% | 41.443% | 80.623% |
| iShares S&P 500 | -0.655% | 2.069% | 21.405% | 70.737% |
According to Sievi what are the pros and cons of Pharmacyte Biotech Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
